Rogier Kersseboom

Author PubWeight™ 6.93^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.	Immunity	2007	1.92
2	ANKRD26-related thrombocytopenia and myeloid malignancies.	Blood	2013	1.32
3	MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.	Hum Mutat	2013	1.15
4	Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells.	Semin Immunol	2005	1.12
5	Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.	Blood	2009	0.87
6	Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.	Blood	2004	0.85
7	Hematopoietic Stem Cell Transplantation in a Patient With ICF2 Syndrome Presenting With EBV-Induced Hemophagocytic Lymphohystiocytosis.	Transplantation	2016	0.75
8	Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.	J Pediatr Gastroenterol Nutr	2017	0.75
9	Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.	Int J Hematol	2015	0.75
10	Development and Function of Immune Cells in an Adolescent Patient with a Deficiency in the Interleukin-10 Receptor.	J Pediatr Gastroenterol Nutr	2017	0.75